nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CYP2C18—Omeprazole—Barrett's esophagus	0.282	0.48	CbGbCtD
Tretinoin—CYP1A1—Omeprazole—Barrett's esophagus	0.117	0.199	CbGbCtD
Tretinoin—CYP2C8—Omeprazole—Barrett's esophagus	0.0677	0.115	CbGbCtD
Tretinoin—CYP2C9—Omeprazole—Barrett's esophagus	0.0472	0.0802	CbGbCtD
Tretinoin—CYP3A4—Esomeprazole—Barrett's esophagus	0.0466	0.0791	CbGbCtD
Tretinoin—CYP3A4—Omeprazole—Barrett's esophagus	0.0274	0.0466	CbGbCtD
Tretinoin—GPRC5A—digestive system—Barrett's esophagus	0.00622	0.264	CbGeAlD
Tretinoin—Acitretin—CYP26A1—Barrett's esophagus	0.00559	0.588	CrCbGaD
Tretinoin—Vitamin A—CYP26A1—Barrett's esophagus	0.00391	0.412	CrCbGaD
Tretinoin—CRABP2—smooth muscle tissue—Barrett's esophagus	0.00266	0.113	CbGeAlD
Tretinoin—CYP4A11—digestive system—Barrett's esophagus	0.00233	0.099	CbGeAlD
Tretinoin—ALDH1A1—smooth muscle tissue—Barrett's esophagus	0.00222	0.0945	CbGeAlD
Tretinoin—CRABP2—digestive system—Barrett's esophagus	0.0021	0.0895	CbGeAlD
Tretinoin—ALDH1A1—digestive system—Barrett's esophagus	0.00175	0.0746	CbGeAlD
Tretinoin—CYP2C18—digestive system—Barrett's esophagus	0.00154	0.0656	CbGeAlD
Tretinoin—RARG—digestive system—Barrett's esophagus	0.00153	0.0653	CbGeAlD
Tretinoin—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.000971	0.00413	CcSEcCtD
Tretinoin—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.000971	0.00413	CcSEcCtD
Tretinoin—Injection site reaction—Esomeprazole—Barrett's esophagus	0.000965	0.0041	CcSEcCtD
Tretinoin—Injection site reaction—Omeprazole—Barrett's esophagus	0.000965	0.0041	CcSEcCtD
Tretinoin—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.000949	0.00403	CcSEcCtD
Tretinoin—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.000949	0.00403	CcSEcCtD
Tretinoin—Cystitis—Esomeprazole—Barrett's esophagus	0.000938	0.00399	CcSEcCtD
Tretinoin—Cystitis—Omeprazole—Barrett's esophagus	0.000938	0.00399	CcSEcCtD
Tretinoin—Candida infection—Esomeprazole—Barrett's esophagus	0.000927	0.00394	CcSEcCtD
Tretinoin—Candida infection—Omeprazole—Barrett's esophagus	0.000927	0.00394	CcSEcCtD
Tretinoin—Dry eye—Esomeprazole—Barrett's esophagus	0.000897	0.00381	CcSEcCtD
Tretinoin—Dry eye—Omeprazole—Barrett's esophagus	0.000897	0.00381	CcSEcCtD
Tretinoin—Oesophagitis—Omeprazole—Barrett's esophagus	0.000887	0.00377	CcSEcCtD
Tretinoin—Oesophagitis—Esomeprazole—Barrett's esophagus	0.000887	0.00377	CcSEcCtD
Tretinoin—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.000883	0.00375	CcSEcCtD
Tretinoin—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.000883	0.00375	CcSEcCtD
Tretinoin—Bladder pain—Omeprazole—Barrett's esophagus	0.000878	0.00373	CcSEcCtD
Tretinoin—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.000878	0.00373	CcSEcCtD
Tretinoin—Mouth ulceration—Omeprazole—Barrett's esophagus	0.000878	0.00373	CcSEcCtD
Tretinoin—Bladder pain—Esomeprazole—Barrett's esophagus	0.000878	0.00373	CcSEcCtD
Tretinoin—Lightheadedness—Omeprazole—Barrett's esophagus	0.000869	0.00369	CcSEcCtD
Tretinoin—Lightheadedness—Esomeprazole—Barrett's esophagus	0.000869	0.00369	CcSEcCtD
Tretinoin—CYP2C18—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000854	0.00595	CbGpPWpGaD
Tretinoin—RXRG—Adipogenesis—CYP26A1—Barrett's esophagus	0.000852	0.00594	CbGpPWpGaD
Tretinoin—CYP2C18—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000843	0.00588	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000832	0.0058	CbGpPWpGaD
Tretinoin—Lymphadenopathy—Esomeprazole—Barrett's esophagus	0.000826	0.00351	CcSEcCtD
Tretinoin—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.000826	0.00351	CcSEcCtD
Tretinoin—Ear pain—Omeprazole—Barrett's esophagus	0.000826	0.00351	CcSEcCtD
Tretinoin—Ear pain—Esomeprazole—Barrett's esophagus	0.000826	0.00351	CcSEcCtD
Tretinoin—RARG—Nuclear Receptors—PPARG—Barrett's esophagus	0.00082	0.00572	CbGpPWpGaD
Tretinoin—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00081	0.00345	CcSEcCtD
Tretinoin—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00081	0.00345	CcSEcCtD
Tretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000804	0.00561	CbGpPWpGaD
Tretinoin—NR0B1—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000804	0.00561	CbGpPWpGaD
Tretinoin—Photosensitivity—Esomeprazole—Barrett's esophagus	0.000803	0.00341	CcSEcCtD
Tretinoin—Photosensitivity—Omeprazole—Barrett's esophagus	0.000803	0.00341	CcSEcCtD
Tretinoin—RARA—Adipogenesis—CYP26A1—Barrett's esophagus	0.000801	0.00559	CbGpPWpGaD
Tretinoin—Swelling—Omeprazole—Barrett's esophagus	0.000799	0.0034	CcSEcCtD
Tretinoin—Swelling—Esomeprazole—Barrett's esophagus	0.000799	0.0034	CcSEcCtD
Tretinoin—CYP4A11—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000792	0.00552	CbGpPWpGaD
Tretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000775	0.0054	CbGpPWpGaD
Tretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000771	0.00537	CbGpPWpGaD
Tretinoin—RXRG—Nuclear Receptors—PPARG—Barrett's esophagus	0.00075	0.00523	CbGpPWpGaD
Tretinoin—Visual disturbance—Omeprazole—Barrett's esophagus	0.000744	0.00316	CcSEcCtD
Tretinoin—Visual disturbance—Esomeprazole—Barrett's esophagus	0.000744	0.00316	CcSEcCtD
Tretinoin—Renal impairment—Esomeprazole—Barrett's esophagus	0.000741	0.00315	CcSEcCtD
Tretinoin—Renal impairment—Omeprazole—Barrett's esophagus	0.000741	0.00315	CcSEcCtD
Tretinoin—RARB—Nuclear Receptors—PPARG—Barrett's esophagus	0.000735	0.00513	CbGpPWpGaD
Tretinoin—Arthritis—Omeprazole—Barrett's esophagus	0.000725	0.00308	CcSEcCtD
Tretinoin—Arthritis—Esomeprazole—Barrett's esophagus	0.000725	0.00308	CcSEcCtD
Tretinoin—RXRB—Nuclear Receptors—PPARG—Barrett's esophagus	0.000705	0.00492	CbGpPWpGaD
Tretinoin—RARA—Nuclear Receptors—PPARG—Barrett's esophagus	0.000705	0.00492	CbGpPWpGaD
Tretinoin—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000705	0.003	CcSEcCtD
Tretinoin—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.000705	0.003	CcSEcCtD
Tretinoin—Osteoarthritis—Omeprazole—Barrett's esophagus	0.000705	0.003	CcSEcCtD
Tretinoin—Pain in extremity—Omeprazole—Barrett's esophagus	0.000705	0.003	CcSEcCtD
Tretinoin—Pain in extremity—Esomeprazole—Barrett's esophagus	0.000705	0.003	CcSEcCtD
Tretinoin—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000705	0.003	CcSEcCtD
Tretinoin—CYP1A1—epithelium—Barrett's esophagus	0.000694	0.0295	CbGeAlD
Tretinoin—CYP2C18—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000692	0.00483	CbGpPWpGaD
Tretinoin—Face oedema—Omeprazole—Barrett's esophagus	0.000681	0.00289	CcSEcCtD
Tretinoin—Face oedema—Esomeprazole—Barrett's esophagus	0.000681	0.00289	CcSEcCtD
Tretinoin—Irritability—Omeprazole—Barrett's esophagus	0.000673	0.00286	CcSEcCtD
Tretinoin—Irritability—Esomeprazole—Barrett's esophagus	0.000673	0.00286	CcSEcCtD
Tretinoin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000661	0.00461	CbGpPWpGaD
Tretinoin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000661	0.00461	CbGpPWpGaD
Tretinoin—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00066	0.00281	CcSEcCtD
Tretinoin—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00066	0.00281	CcSEcCtD
Tretinoin—RARG—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000648	0.00452	CbGpPWpGaD
Tretinoin—Dry skin—Esomeprazole—Barrett's esophagus	0.000646	0.00275	CcSEcCtD
Tretinoin—Dry skin—Omeprazole—Barrett's esophagus	0.000646	0.00275	CcSEcCtD
Tretinoin—RXRG—Adipogenesis—BMP4—Barrett's esophagus	0.000646	0.0045	CbGpPWpGaD
Tretinoin—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000635	0.0027	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000635	0.0027	CcSEcCtD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000632	0.00441	CbGpPWpGaD
Tretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000628	0.00438	CbGpPWpGaD
Tretinoin—Gastritis—Esomeprazole—Barrett's esophagus	0.000624	0.00265	CcSEcCtD
Tretinoin—Gastritis—Omeprazole—Barrett's esophagus	0.000624	0.00265	CcSEcCtD
Tretinoin—Abdominal distension—Omeprazole—Barrett's esophagus	0.000613	0.00261	CcSEcCtD
Tretinoin—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000613	0.00261	CcSEcCtD
Tretinoin—Dysphagia—Esomeprazole—Barrett's esophagus	0.000609	0.00259	CcSEcCtD
Tretinoin—Dysphagia—Omeprazole—Barrett's esophagus	0.000609	0.00259	CcSEcCtD
Tretinoin—Asthma—Omeprazole—Barrett's esophagus	0.000609	0.00259	CcSEcCtD
Tretinoin—Asthma—Esomeprazole—Barrett's esophagus	0.000609	0.00259	CcSEcCtD
Tretinoin—RARA—Adipogenesis—BMP4—Barrett's esophagus	0.000607	0.00423	CbGpPWpGaD
Tretinoin—Bronchospasm—Omeprazole—Barrett's esophagus	0.000599	0.00255	CcSEcCtD
Tretinoin—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000599	0.00255	CcSEcCtD
Tretinoin—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000597	0.00254	CcSEcCtD
Tretinoin—Pancreatitis—Omeprazole—Barrett's esophagus	0.000597	0.00254	CcSEcCtD
Tretinoin—Sweating increased—Omeprazole—Barrett's esophagus	0.000593	0.00252	CcSEcCtD
Tretinoin—Sweating increased—Esomeprazole—Barrett's esophagus	0.000593	0.00252	CcSEcCtD
Tretinoin—RXRG—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000593	0.00413	CbGpPWpGaD
Tretinoin—CYP1A1—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000592	0.00413	CbGpPWpGaD
Tretinoin—RARB—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000581	0.00405	CbGpPWpGaD
Tretinoin—Dysuria—Omeprazole—Barrett's esophagus	0.00057	0.00242	CcSEcCtD
Tretinoin—Neutropenia—Omeprazole—Barrett's esophagus	0.00057	0.00242	CcSEcCtD
Tretinoin—Neutropenia—Esomeprazole—Barrett's esophagus	0.00057	0.00242	CcSEcCtD
Tretinoin—Dysuria—Esomeprazole—Barrett's esophagus	0.00057	0.00242	CcSEcCtD
Tretinoin—RXRA—Transcription factor regulation in adipogenesis—PPARG—Barrett's esophagus	0.000569	0.00397	CbGpPWpGaD
Tretinoin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000568	0.00396	CbGpPWpGaD
Tretinoin—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000566	0.00241	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000566	0.00241	CcSEcCtD
Tretinoin—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000563	0.00239	CcSEcCtD
Tretinoin—Pollakiuria—Omeprazole—Barrett's esophagus	0.000563	0.00239	CcSEcCtD
Tretinoin—CYP3A7—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00056	0.00391	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000559	0.00389	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000559	0.00389	CbGpPWpGaD
Tretinoin—RARA—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000557	0.00389	CbGpPWpGaD
Tretinoin—RXRB—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000557	0.00389	CbGpPWpGaD
Tretinoin—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000556	0.00236	CcSEcCtD
Tretinoin—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000556	0.00236	CcSEcCtD
Tretinoin—Weight increased—Omeprazole—Barrett's esophagus	0.000554	0.00236	CcSEcCtD
Tretinoin—Weight increased—Esomeprazole—Barrett's esophagus	0.000554	0.00236	CcSEcCtD
Tretinoin—Weight decreased—Omeprazole—Barrett's esophagus	0.000551	0.00234	CcSEcCtD
Tretinoin—Weight decreased—Esomeprazole—Barrett's esophagus	0.000551	0.00234	CcSEcCtD
Tretinoin—Infestation NOS—Omeprazole—Barrett's esophagus	0.000543	0.00231	CcSEcCtD
Tretinoin—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000543	0.00231	CcSEcCtD
Tretinoin—Infestation—Omeprazole—Barrett's esophagus	0.000543	0.00231	CcSEcCtD
Tretinoin—Infestation—Esomeprazole—Barrett's esophagus	0.000543	0.00231	CcSEcCtD
Tretinoin—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000543	0.00378	CbGpPWpGaD
Tretinoin—Depression—Omeprazole—Barrett's esophagus	0.000542	0.0023	CcSEcCtD
Tretinoin—Depression—Esomeprazole—Barrett's esophagus	0.000542	0.0023	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000539	0.00229	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000539	0.00229	CcSEcCtD
Tretinoin—Renal failure—Esomeprazole—Barrett's esophagus	0.000534	0.00227	CcSEcCtD
Tretinoin—Renal failure—Omeprazole—Barrett's esophagus	0.000534	0.00227	CcSEcCtD
Tretinoin—Stomatitis—Esomeprazole—Barrett's esophagus	0.00053	0.00225	CcSEcCtD
Tretinoin—Stomatitis—Omeprazole—Barrett's esophagus	0.00053	0.00225	CcSEcCtD
Tretinoin—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000528	0.00225	CcSEcCtD
Tretinoin—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000528	0.00225	CcSEcCtD
Tretinoin—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000528	0.00225	CcSEcCtD
Tretinoin—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000528	0.00225	CcSEcCtD
Tretinoin—CYP1A1—digestive system—Barrett's esophagus	0.000528	0.0225	CbGeAlD
Tretinoin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000523	0.00365	CbGpPWpGaD
Tretinoin—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00052	0.00363	CbGpPWpGaD
Tretinoin—Haematuria—Esomeprazole—Barrett's esophagus	0.000518	0.0022	CcSEcCtD
Tretinoin—Haematuria—Omeprazole—Barrett's esophagus	0.000518	0.0022	CcSEcCtD
Tretinoin—CYP3A5—digestive system—Barrett's esophagus	0.000516	0.022	CbGeAlD
Tretinoin—CYP2A6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000514	0.00358	CbGpPWpGaD
Tretinoin—CYP2B6—digestive system—Barrett's esophagus	0.000513	0.0218	CbGeAlD
Tretinoin—Epistaxis—Esomeprazole—Barrett's esophagus	0.000512	0.00218	CcSEcCtD
Tretinoin—Epistaxis—Omeprazole—Barrett's esophagus	0.000512	0.00218	CcSEcCtD
Tretinoin—Sinusitis—Esomeprazole—Barrett's esophagus	0.00051	0.00217	CcSEcCtD
Tretinoin—Sinusitis—Omeprazole—Barrett's esophagus	0.00051	0.00217	CcSEcCtD
Tretinoin—CYP2C9—digestive system—Barrett's esophagus	0.000508	0.0216	CbGeAlD
Tretinoin—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000507	0.00216	CcSEcCtD
Tretinoin—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000507	0.00216	CcSEcCtD
Tretinoin—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000506	0.00353	CbGpPWpGaD
Tretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Barrett's esophagus	0.000498	0.00347	CbGpPWpGaD
Tretinoin—Hepatitis—Omeprazole—Barrett's esophagus	0.000488	0.00207	CcSEcCtD
Tretinoin—Hepatitis—Esomeprazole—Barrett's esophagus	0.000488	0.00207	CcSEcCtD
Tretinoin—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000485	0.00206	CcSEcCtD
Tretinoin—Hallucination—Omeprazole—Barrett's esophagus	0.000485	0.00206	CcSEcCtD
Tretinoin—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000485	0.00206	CcSEcCtD
Tretinoin—Hallucination—Esomeprazole—Barrett's esophagus	0.000485	0.00206	CcSEcCtD
Tretinoin—Pharyngitis—Omeprazole—Barrett's esophagus	0.000484	0.00206	CcSEcCtD
Tretinoin—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000484	0.00206	CcSEcCtD
Tretinoin—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000482	0.00205	CcSEcCtD
Tretinoin—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000482	0.00205	CcSEcCtD
Tretinoin—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00048	0.00204	CcSEcCtD
Tretinoin—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00048	0.00204	CcSEcCtD
Tretinoin—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000478	0.00203	CcSEcCtD
Tretinoin—Urethral disorder—Omeprazole—Barrett's esophagus	0.000478	0.00203	CcSEcCtD
Tretinoin—Visual impairment—Esomeprazole—Barrett's esophagus	0.00047	0.002	CcSEcCtD
Tretinoin—Visual impairment—Omeprazole—Barrett's esophagus	0.00047	0.002	CcSEcCtD
Tretinoin—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000461	0.00196	CcSEcCtD
Tretinoin—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000461	0.00196	CcSEcCtD
Tretinoin—CYP3A7—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00046	0.00321	CbGpPWpGaD
Tretinoin—Eye disorder—Omeprazole—Barrett's esophagus	0.000456	0.00194	CcSEcCtD
Tretinoin—Eye disorder—Esomeprazole—Barrett's esophagus	0.000456	0.00194	CcSEcCtD
Tretinoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000456	0.00318	CbGpPWpGaD
Tretinoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000456	0.00318	CbGpPWpGaD
Tretinoin—Tinnitus—Omeprazole—Barrett's esophagus	0.000455	0.00193	CcSEcCtD
Tretinoin—Tinnitus—Esomeprazole—Barrett's esophagus	0.000455	0.00193	CcSEcCtD
Tretinoin—Flushing—Esomeprazole—Barrett's esophagus	0.000453	0.00192	CcSEcCtD
Tretinoin—Flushing—Omeprazole—Barrett's esophagus	0.000453	0.00192	CcSEcCtD
Tretinoin—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000448	0.00313	CbGpPWpGaD
Tretinoin—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000442	0.00308	CbGpPWpGaD
Tretinoin—Chills—Esomeprazole—Barrett's esophagus	0.000438	0.00186	CcSEcCtD
Tretinoin—Chills—Omeprazole—Barrett's esophagus	0.000438	0.00186	CcSEcCtD
Tretinoin—Alopecia—Esomeprazole—Barrett's esophagus	0.000431	0.00183	CcSEcCtD
Tretinoin—Alopecia—Omeprazole—Barrett's esophagus	0.000431	0.00183	CcSEcCtD
Tretinoin—Mental disorder—Esomeprazole—Barrett's esophagus	0.000427	0.00182	CcSEcCtD
Tretinoin—Mental disorder—Omeprazole—Barrett's esophagus	0.000427	0.00182	CcSEcCtD
Tretinoin—Malnutrition—Esomeprazole—Barrett's esophagus	0.000425	0.00181	CcSEcCtD
Tretinoin—Malnutrition—Omeprazole—Barrett's esophagus	0.000425	0.00181	CcSEcCtD
Tretinoin—NR0B1—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000422	0.00294	CbGpPWpGaD
Tretinoin—CYP2A6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000422	0.00294	CbGpPWpGaD
Tretinoin—CYP4A11—Biological oxidations—CYP26A1—Barrett's esophagus	0.000421	0.00293	CbGpPWpGaD
Tretinoin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00042	0.00293	CbGpPWpGaD
Tretinoin—Flatulence—Omeprazole—Barrett's esophagus	0.000418	0.00178	CcSEcCtD
Tretinoin—Flatulence—Esomeprazole—Barrett's esophagus	0.000418	0.00178	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—CYP26A1—Barrett's esophagus	0.000417	0.00291	CbGpPWpGaD
Tretinoin—Tension—Esomeprazole—Barrett's esophagus	0.000417	0.00177	CcSEcCtD
Tretinoin—Tension—Omeprazole—Barrett's esophagus	0.000417	0.00177	CcSEcCtD
Tretinoin—CYP2B6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000414	0.00289	CbGpPWpGaD
Tretinoin—Nervousness—Esomeprazole—Barrett's esophagus	0.000412	0.00175	CcSEcCtD
Tretinoin—Nervousness—Omeprazole—Barrett's esophagus	0.000412	0.00175	CcSEcCtD
Tretinoin—Back pain—Esomeprazole—Barrett's esophagus	0.000411	0.00175	CcSEcCtD
Tretinoin—Back pain—Omeprazole—Barrett's esophagus	0.000411	0.00175	CcSEcCtD
Tretinoin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00041	0.00286	CbGpPWpGaD
Tretinoin—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000405	0.00282	CbGpPWpGaD
Tretinoin—Vision blurred—Esomeprazole—Barrett's esophagus	0.0004	0.0017	CcSEcCtD
Tretinoin—Vision blurred—Omeprazole—Barrett's esophagus	0.0004	0.0017	CcSEcCtD
Tretinoin—Tremor—Omeprazole—Barrett's esophagus	0.000398	0.00169	CcSEcCtD
Tretinoin—Tremor—Esomeprazole—Barrett's esophagus	0.000398	0.00169	CcSEcCtD
Tretinoin—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000394	0.00167	CcSEcCtD
Tretinoin—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000394	0.00167	CcSEcCtD
Tretinoin—Anaemia—Esomeprazole—Barrett's esophagus	0.000392	0.00167	CcSEcCtD
Tretinoin—Anaemia—Omeprazole—Barrett's esophagus	0.000392	0.00167	CcSEcCtD
Tretinoin—Agitation—Esomeprazole—Barrett's esophagus	0.00039	0.00166	CcSEcCtD
Tretinoin—Agitation—Omeprazole—Barrett's esophagus	0.00039	0.00166	CcSEcCtD
Tretinoin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—Barrett's esophagus	0.000388	0.0027	CbGpPWpGaD
Tretinoin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000388	0.0027	CbGpPWpGaD
Tretinoin—CYP3A4—digestive system—Barrett's esophagus	0.000387	0.0165	CbGeAlD
Tretinoin—Malaise—Esomeprazole—Barrett's esophagus	0.000383	0.00163	CcSEcCtD
Tretinoin—Malaise—Omeprazole—Barrett's esophagus	0.000383	0.00163	CcSEcCtD
Tretinoin—CYP1A1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000383	0.00267	CbGpPWpGaD
Tretinoin—GPRC5A—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000376	0.00262	CbGpPWpGaD
Tretinoin—Palpitations—Esomeprazole—Barrett's esophagus	0.000375	0.0016	CcSEcCtD
Tretinoin—Palpitations—Omeprazole—Barrett's esophagus	0.000375	0.0016	CcSEcCtD
Tretinoin—Cough—Esomeprazole—Barrett's esophagus	0.00037	0.00158	CcSEcCtD
Tretinoin—Cough—Omeprazole—Barrett's esophagus	0.00037	0.00158	CcSEcCtD
Tretinoin—CYP2C18—Biological oxidations—CYP26A1—Barrett's esophagus	0.000368	0.00256	CbGpPWpGaD
Tretinoin—RXRA—Nuclear Receptors—PPARG—Barrett's esophagus	0.000367	0.00256	CbGpPWpGaD
Tretinoin—Hypertension—Esomeprazole—Barrett's esophagus	0.000367	0.00156	CcSEcCtD
Tretinoin—Hypertension—Omeprazole—Barrett's esophagus	0.000367	0.00156	CcSEcCtD
Tretinoin—CYP2C18—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000363	0.00253	CbGpPWpGaD
Tretinoin—Arthralgia—Esomeprazole—Barrett's esophagus	0.000361	0.00154	CcSEcCtD
Tretinoin—Myalgia—Esomeprazole—Barrett's esophagus	0.000361	0.00154	CcSEcCtD
Tretinoin—Chest pain—Esomeprazole—Barrett's esophagus	0.000361	0.00154	CcSEcCtD
Tretinoin—Arthralgia—Omeprazole—Barrett's esophagus	0.000361	0.00154	CcSEcCtD
Tretinoin—Myalgia—Omeprazole—Barrett's esophagus	0.000361	0.00154	CcSEcCtD
Tretinoin—Chest pain—Omeprazole—Barrett's esophagus	0.000361	0.00154	CcSEcCtD
Tretinoin—Anxiety—Esomeprazole—Barrett's esophagus	0.00036	0.00153	CcSEcCtD
Tretinoin—Anxiety—Omeprazole—Barrett's esophagus	0.00036	0.00153	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000359	0.00153	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000359	0.00153	CcSEcCtD
Tretinoin—Discomfort—Omeprazole—Barrett's esophagus	0.000357	0.00152	CcSEcCtD
Tretinoin—Discomfort—Esomeprazole—Barrett's esophagus	0.000357	0.00152	CcSEcCtD
Tretinoin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000355	0.00248	CbGpPWpGaD
Tretinoin—Dry mouth—Esomeprazole—Barrett's esophagus	0.000353	0.0015	CcSEcCtD
Tretinoin—Dry mouth—Omeprazole—Barrett's esophagus	0.000353	0.0015	CcSEcCtD
Tretinoin—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000351	0.00245	CbGpPWpGaD
Tretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.00035	0.00244	CbGpPWpGaD
Tretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.00035	0.00244	CbGpPWpGaD
Tretinoin—Confusional state—Esomeprazole—Barrett's esophagus	0.000349	0.00149	CcSEcCtD
Tretinoin—Confusional state—Omeprazole—Barrett's esophagus	0.000349	0.00149	CcSEcCtD
Tretinoin—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000346	0.00147	CcSEcCtD
Tretinoin—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000346	0.00147	CcSEcCtD
Tretinoin—Infection—Esomeprazole—Barrett's esophagus	0.000344	0.00146	CcSEcCtD
Tretinoin—Infection—Omeprazole—Barrett's esophagus	0.000344	0.00146	CcSEcCtD
Tretinoin—Shock—Esomeprazole—Barrett's esophagus	0.000341	0.00145	CcSEcCtD
Tretinoin—Shock—Omeprazole—Barrett's esophagus	0.000341	0.00145	CcSEcCtD
Tretinoin—CYP2B6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00034	0.00237	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.00034	0.00237	CbGpPWpGaD
Tretinoin—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00034	0.00144	CcSEcCtD
Tretinoin—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00034	0.00144	CcSEcCtD
Tretinoin—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000339	0.00144	CcSEcCtD
Tretinoin—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000339	0.00144	CcSEcCtD
Tretinoin—Tachycardia—Esomeprazole—Barrett's esophagus	0.000338	0.00144	CcSEcCtD
Tretinoin—Tachycardia—Omeprazole—Barrett's esophagus	0.000338	0.00144	CcSEcCtD
Tretinoin—Skin disorder—Omeprazole—Barrett's esophagus	0.000337	0.00143	CcSEcCtD
Tretinoin—Skin disorder—Esomeprazole—Barrett's esophagus	0.000337	0.00143	CcSEcCtD
Tretinoin—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000335	0.00142	CcSEcCtD
Tretinoin—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000335	0.00142	CcSEcCtD
Tretinoin—RXRA—Biological oxidations—CYP26A1—Barrett's esophagus	0.000334	0.00233	CbGpPWpGaD
Tretinoin—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000333	0.00232	CbGpPWpGaD
Tretinoin—Anorexia—Esomeprazole—Barrett's esophagus	0.00033	0.0014	CcSEcCtD
Tretinoin—Anorexia—Omeprazole—Barrett's esophagus	0.00033	0.0014	CcSEcCtD
Tretinoin—RXRA—Adipogenesis—BMP4—Barrett's esophagus	0.000316	0.00221	CbGpPWpGaD
Tretinoin—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000316	0.00134	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000316	0.00134	CcSEcCtD
Tretinoin—CYP1A1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000314	0.00219	CbGpPWpGaD
Tretinoin—Insomnia—Omeprazole—Barrett's esophagus	0.000313	0.00133	CcSEcCtD
Tretinoin—Insomnia—Esomeprazole—Barrett's esophagus	0.000313	0.00133	CcSEcCtD
Tretinoin—Paraesthesia—Omeprazole—Barrett's esophagus	0.000311	0.00132	CcSEcCtD
Tretinoin—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000311	0.00132	CcSEcCtD
Tretinoin—RXRG—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000311	0.00217	CbGpPWpGaD
Tretinoin—Dyspnoea—Omeprazole—Barrett's esophagus	0.000309	0.00131	CcSEcCtD
Tretinoin—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000309	0.00131	CcSEcCtD
Tretinoin—Somnolence—Omeprazole—Barrett's esophagus	0.000308	0.00131	CcSEcCtD
Tretinoin—Somnolence—Esomeprazole—Barrett's esophagus	0.000308	0.00131	CcSEcCtD
Tretinoin—RARB—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000305	0.00213	CbGpPWpGaD
Tretinoin—Dyspepsia—Omeprazole—Barrett's esophagus	0.000305	0.0013	CcSEcCtD
Tretinoin—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000305	0.0013	CcSEcCtD
Tretinoin—Decreased appetite—Omeprazole—Barrett's esophagus	0.000301	0.00128	CcSEcCtD
Tretinoin—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000301	0.00128	CcSEcCtD
Tretinoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000301	0.0021	CbGpPWpGaD
Tretinoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000301	0.0021	CbGpPWpGaD
Tretinoin—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000299	0.00127	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000299	0.00127	CcSEcCtD
Tretinoin—Fatigue—Esomeprazole—Barrett's esophagus	0.000299	0.00127	CcSEcCtD
Tretinoin—Fatigue—Omeprazole—Barrett's esophagus	0.000299	0.00127	CcSEcCtD
Tretinoin—Pain—Omeprazole—Barrett's esophagus	0.000296	0.00126	CcSEcCtD
Tretinoin—Constipation—Esomeprazole—Barrett's esophagus	0.000296	0.00126	CcSEcCtD
Tretinoin—Constipation—Omeprazole—Barrett's esophagus	0.000296	0.00126	CcSEcCtD
Tretinoin—Pain—Esomeprazole—Barrett's esophagus	0.000296	0.00126	CcSEcCtD
Tretinoin—CYP4A11—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000293	0.00204	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000292	0.00204	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000292	0.00204	CbGpPWpGaD
Tretinoin—RXRA—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00029	0.00202	CbGpPWpGaD
Tretinoin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000289	0.00202	CbGpPWpGaD
Tretinoin—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000288	0.00201	CbGpPWpGaD
Tretinoin—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000286	0.00121	CcSEcCtD
Tretinoin—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000286	0.00121	CcSEcCtD
Tretinoin—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000286	0.00199	CbGpPWpGaD
Tretinoin—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000283	0.0012	CcSEcCtD
Tretinoin—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000283	0.0012	CcSEcCtD
Tretinoin—RXRG—Adipogenesis—PPARG—Barrett's esophagus	0.00028	0.00195	CbGpPWpGaD
Tretinoin—Urticaria—Esomeprazole—Barrett's esophagus	0.000275	0.00117	CcSEcCtD
Tretinoin—Urticaria—Omeprazole—Barrett's esophagus	0.000275	0.00117	CcSEcCtD
Tretinoin—Body temperature increased—Omeprazole—Barrett's esophagus	0.000274	0.00116	CcSEcCtD
Tretinoin—Abdominal pain—Omeprazole—Barrett's esophagus	0.000274	0.00116	CcSEcCtD
Tretinoin—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000274	0.00116	CcSEcCtD
Tretinoin—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000274	0.00116	CcSEcCtD
Tretinoin—RARA—Adipogenesis—PPARG—Barrett's esophagus	0.000264	0.00184	CbGpPWpGaD
Tretinoin—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000255	0.00109	CcSEcCtD
Tretinoin—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000255	0.00109	CcSEcCtD
Tretinoin—CRABP1—Metabolism—PTGES—Barrett's esophagus	0.000249	0.00173	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PTGES—Barrett's esophagus	0.000249	0.00173	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PTGES—Barrett's esophagus	0.000249	0.00173	CbGpPWpGaD
Tretinoin—Asthenia—Omeprazole—Barrett's esophagus	0.000249	0.00106	CcSEcCtD
Tretinoin—Asthenia—Esomeprazole—Barrett's esophagus	0.000249	0.00106	CcSEcCtD
Tretinoin—Pruritus—Esomeprazole—Barrett's esophagus	0.000245	0.00104	CcSEcCtD
Tretinoin—Pruritus—Omeprazole—Barrett's esophagus	0.000245	0.00104	CcSEcCtD
Tretinoin—CYP3A7—Biological oxidations—CYP26A1—Barrett's esophagus	0.000244	0.0017	CbGpPWpGaD
Tretinoin—CYP3A7—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000241	0.00168	CbGpPWpGaD
Tretinoin—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000237	0.00101	CcSEcCtD
Tretinoin—Diarrhoea—Omeprazole—Barrett's esophagus	0.000237	0.00101	CcSEcCtD
Tretinoin—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000235	0.00164	CbGpPWpGaD
Tretinoin—Dizziness—Omeprazole—Barrett's esophagus	0.000229	0.000974	CcSEcCtD
Tretinoin—Dizziness—Esomeprazole—Barrett's esophagus	0.000229	0.000974	CcSEcCtD
Tretinoin—CYP2A6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000224	0.00156	CbGpPWpGaD
Tretinoin—Vomiting—Esomeprazole—Barrett's esophagus	0.00022	0.000937	CcSEcCtD
Tretinoin—Vomiting—Omeprazole—Barrett's esophagus	0.00022	0.000937	CcSEcCtD
Tretinoin—CYP4A11—NRF2 pathway—HGF—Barrett's esophagus	0.00022	0.00154	CbGpPWpGaD
Tretinoin—Rash—Omeprazole—Barrett's esophagus	0.000218	0.000929	CcSEcCtD
Tretinoin—Rash—Esomeprazole—Barrett's esophagus	0.000218	0.000929	CcSEcCtD
Tretinoin—Dermatitis—Omeprazole—Barrett's esophagus	0.000218	0.000928	CcSEcCtD
Tretinoin—Dermatitis—Esomeprazole—Barrett's esophagus	0.000218	0.000928	CcSEcCtD
Tretinoin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000218	0.00152	CbGpPWpGaD
Tretinoin—Headache—Esomeprazole—Barrett's esophagus	0.000217	0.000923	CcSEcCtD
Tretinoin—Headache—Omeprazole—Barrett's esophagus	0.000217	0.000923	CcSEcCtD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000213	0.00149	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000209	0.00146	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—Barrett's esophagus	0.000209	0.00146	CbGpPWpGaD
Tretinoin—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000208	0.00145	CbGpPWpGaD
Tretinoin—Nausea—Esomeprazole—Barrett's esophagus	0.000206	0.000875	CcSEcCtD
Tretinoin—Nausea—Omeprazole—Barrett's esophagus	0.000206	0.000875	CcSEcCtD
Tretinoin—NR0B1—Gene Expression—NR1I2—Barrett's esophagus	0.000203	0.00142	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000201	0.0014	CbGpPWpGaD
Tretinoin—CYP4A11—PPARA activates gene expression—PPARG—Barrett's esophagus	0.000198	0.00138	CbGpPWpGaD
Tretinoin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.000194	0.00135	CbGpPWpGaD
Tretinoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000191	0.00133	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—CYP26A1—Barrett's esophagus	0.000189	0.00131	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—CYP26A1—Barrett's esophagus	0.000189	0.00131	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—CYP26A1—Barrett's esophagus	0.000189	0.00131	CbGpPWpGaD
Tretinoin—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000188	0.00131	CbGpPWpGaD
Tretinoin—CYP2B6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000181	0.00126	CbGpPWpGaD
Tretinoin—CYP2B6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000178	0.00124	CbGpPWpGaD
Tretinoin—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000177	0.00123	CbGpPWpGaD
Tretinoin—RXRA—NRF2 pathway—HGF—Barrett's esophagus	0.000175	0.00122	CbGpPWpGaD
Tretinoin—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000174	0.00122	CbGpPWpGaD
Tretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—Barrett's esophagus	0.000169	0.00118	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000169	0.00118	CbGpPWpGaD
Tretinoin—CYP1A1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000167	0.00116	CbGpPWpGaD
Tretinoin—CYP1A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000165	0.00115	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—NR1I2—Barrett's esophagus	0.000164	0.00114	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000159	0.00111	CbGpPWpGaD
Tretinoin—RXRA—PPARA activates gene expression—PPARG—Barrett's esophagus	0.000157	0.00109	CbGpPWpGaD
Tretinoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000155	0.00108	CbGpPWpGaD
Tretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.000154	0.00107	CbGpPWpGaD
Tretinoin—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000153	0.00107	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000152	0.00106	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000152	0.00106	CbGpPWpGaD
Tretinoin—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000151	0.00105	CbGpPWpGaD
Tretinoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00015	0.00105	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—NR1I2—Barrett's esophagus	0.00015	0.00104	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—NR1I2—Barrett's esophagus	0.000147	0.00102	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000143	0.000999	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—NR1I2—Barrett's esophagus	0.000141	0.000982	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—NR1I2—Barrett's esophagus	0.000141	0.000982	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000139	0.000971	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000139	0.000971	CbGpPWpGaD
Tretinoin—NR0B1—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000139	0.000968	CbGpPWpGaD
Tretinoin—RXRA—Adipogenesis—PPARG—Barrett's esophagus	0.000137	0.000958	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—SLC9A1—Barrett's esophagus	0.000136	0.000948	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—SLC9A1—Barrett's esophagus	0.000136	0.000948	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—SLC9A1—Barrett's esophagus	0.000136	0.000948	CbGpPWpGaD
Tretinoin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000134	0.000931	CbGpPWpGaD
Tretinoin—CYP2A6—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000129	0.000902	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000128	0.000891	CbGpPWpGaD
Tretinoin—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000125	0.000869	CbGpPWpGaD
Tretinoin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000124	0.000866	CbGpPWpGaD
Tretinoin—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000123	0.000857	CbGpPWpGaD
Tretinoin—CYP2A6—NRF2 pathway—HGF—Barrett's esophagus	0.000117	0.000818	CbGpPWpGaD
Tretinoin—CYP1A1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000116	0.00081	CbGpPWpGaD
Tretinoin—RARG—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000112	0.00078	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.00011	0.000764	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.00011	0.000764	CbGpPWpGaD
Tretinoin—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000106	0.000742	CbGpPWpGaD
Tretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000106	0.000738	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000105	0.00073	CbGpPWpGaD
Tretinoin—RXRG—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000102	0.000714	CbGpPWpGaD
Tretinoin—RARB—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.0001	0.0007	CbGpPWpGaD
Tretinoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	9.89e-05	0.00069	CbGpPWpGaD
Tretinoin—RXRB—Generic Transcription Pathway—PPARG—Barrett's esophagus	9.62e-05	0.000671	CbGpPWpGaD
Tretinoin—RARA—Generic Transcription Pathway—PPARG—Barrett's esophagus	9.62e-05	0.000671	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGES—Barrett's esophagus	9.49e-05	0.000662	CbGpPWpGaD
Tretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	9.46e-05	0.00066	CbGpPWpGaD
Tretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	9.07e-05	0.000633	CbGpPWpGaD
Tretinoin—RXRA—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	8.78e-05	0.000612	CbGpPWpGaD
Tretinoin—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.66e-05	0.000604	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.46e-05	0.00059	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGES—Barrett's esophagus	8.3e-05	0.000579	CbGpPWpGaD
Tretinoin—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	8.22e-05	0.000573	CbGpPWpGaD
Tretinoin—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	8.1e-05	0.000565	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	7.94e-05	0.000554	CbGpPWpGaD
Tretinoin—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	7.86e-05	0.000548	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.76e-05	0.000541	CbGpPWpGaD
Tretinoin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	7.69e-05	0.000536	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGES—Barrett's esophagus	7.53e-05	0.000525	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NR1I2—Barrett's esophagus	7.34e-05	0.000512	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CYP26A1—Barrett's esophagus	7.2e-05	0.000502	CbGpPWpGaD
Tretinoin—NR0B1—Gene Expression—PPARG—Barrett's esophagus	6.69e-05	0.000466	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.31e-05	0.00044	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CYP26A1—Barrett's esophagus	6.29e-05	0.000439	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PPARG—Barrett's esophagus	6.2e-05	0.000433	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PPARG—Barrett's esophagus	6.2e-05	0.000433	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PPARG—Barrett's esophagus	6.2e-05	0.000433	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP26A1—Barrett's esophagus	5.71e-05	0.000398	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGES—Barrett's esophagus	5.52e-05	0.000385	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—PPARG—Barrett's esophagus	5.39e-05	0.000376	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.32e-05	0.000371	CbGpPWpGaD
Tretinoin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	5.3e-05	0.000369	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—SLC9A1—Barrett's esophagus	5.19e-05	0.000362	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGES—Barrett's esophagus	5.06e-05	0.000353	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—PPARG—Barrett's esophagus	5.02e-05	0.00035	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—PPARG—Barrett's esophagus	4.93e-05	0.000344	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PTGS2—Barrett's esophagus	4.88e-05	0.00034	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PTGS2—Barrett's esophagus	4.88e-05	0.00034	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PTGS2—Barrett's esophagus	4.88e-05	0.00034	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—PPARG—Barrett's esophagus	4.83e-05	0.000337	CbGpPWpGaD
Tretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.73e-05	0.00033	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—PPARG—Barrett's esophagus	4.72e-05	0.000329	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—PPARG—Barrett's esophagus	4.63e-05	0.000323	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—PPARG—Barrett's esophagus	4.63e-05	0.000323	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—SLC9A1—Barrett's esophagus	4.53e-05	0.000316	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	4.22e-05	0.000294	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.18e-05	0.000292	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP26A1—Barrett's esophagus	4.18e-05	0.000292	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—SLC9A1—Barrett's esophagus	4.11e-05	0.000287	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGES—Barrett's esophagus	4.08e-05	0.000284	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGES—Barrett's esophagus	3.99e-05	0.000278	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP26A1—Barrett's esophagus	3.83e-05	0.000267	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—RELA—Barrett's esophagus	3.82e-05	0.000267	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGES—Barrett's esophagus	3.77e-05	0.000263	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGES—Barrett's esophagus	3.45e-05	0.000241	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.32e-05	0.000231	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	3.09e-05	0.000216	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	3.02e-05	0.000211	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—SLC9A1—Barrett's esophagus	3.01e-05	0.00021	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	2.86e-05	0.000199	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGES—Barrett's esophagus	2.81e-05	0.000196	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—SLC9A1—Barrett's esophagus	2.76e-05	0.000193	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	2.62e-05	0.000183	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—PPARG—Barrett's esophagus	2.41e-05	0.000168	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PPARG—Barrett's esophagus	2.37e-05	0.000165	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	2.23e-05	0.000155	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	2.18e-05	0.000152	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.13e-05	0.000149	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.11e-05	0.000147	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PPARG—Barrett's esophagus	2.07e-05	0.000144	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	2.06e-05	0.000144	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.93e-05	0.000135	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	1.89e-05	0.000132	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PPARG—Barrett's esophagus	1.88e-05	0.000131	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—Barrett's esophagus	1.86e-05	0.00013	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGES—Barrett's esophagus	1.85e-05	0.000129	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.66e-05	0.000116	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—Barrett's esophagus	1.63e-05	0.000114	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.57e-05	0.00011	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.54e-05	0.000107	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.52e-05	0.000106	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—Barrett's esophagus	1.48e-05	0.000103	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.41e-05	9.8e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PPARG—Barrett's esophagus	1.38e-05	9.59e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PPARG—Barrett's esophagus	1.26e-05	8.79e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.24e-05	8.63e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—Barrett's esophagus	1.08e-05	7.55e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PPARG—Barrett's esophagus	1.02e-05	7.09e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.01e-05	7.06e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PPARG—Barrett's esophagus	9.95e-06	6.93e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—Barrett's esophagus	9.92e-06	6.92e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PPARG—Barrett's esophagus	9.4e-06	6.55e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PPARG—Barrett's esophagus	8.61e-06	6.01e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	8e-06	5.58e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	7.82e-06	5.46e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	7.39e-06	5.15e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PPARG—Barrett's esophagus	7.01e-06	4.89e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	6.78e-06	4.73e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	5.51e-06	3.85e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARG—Barrett's esophagus	4.62e-06	3.22e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	3.64e-06	2.54e-05	CbGpPWpGaD
